H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
18%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Get your full text copy in PDF

Nitric oxide therapy in Persistent Pulmonary Hypertension of the Newborns (PPHN) – predictors of survival in a single centre experience

Danuta Więcek- Włodarska, Janusz Świetliński, Iwona Maruniak-Chudek, Barbara Goc, Victor G. Phillips, Klaudiusz Bober

Med Sci Monit 2004; 10(2): 69-75

ID: 11843


Background: We summarize 3-years experience with iNO treatment in PPHN newborns in search for predictors of the outcome. Material/Methods: Out of 30 PPHN newborns treated with iNO, 22 survived and 8 died. Arterial blood gases, saturation, ventilator settings and echocardiography were obtained at least every 12 hours up to 24hrs after iNO weaning.Results: Survivals did not differ from fatal cases in respect to gestational age and Apgar scores, but had higher birth weight (3094±940 vs. 2075±1018 g; p

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree